Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Maternal prenatal depression predicts post-partum depression and increases risk of prematurity and low birth weight. These effects may be mediated by altered placental function. We hypothesized that placental function would be influenced by the gestational week of experiencing depressive symptoms and aimed to examine associations between maternal depressive symptoms during pregnancy and placental expression of genes involved in glucocorticoid and serotonin transfer between mother and fetus. Method: We studied women participating in a prospective pregnancy cohort: the Prediction and Prevention of Preeclampsia (PREDO) Study, Helsinki, Finland. Maternal depressive symptoms were assessed at 2-week intervals throughout pregnancy in 56 healthy women with singleton, term pregnancies. Messenger ribonucleic acid (mRNA) levels of glucocorticoid (GR) and mineralocorticoid (MR) receptors and serotonin transporter (SLC6A4), 11β-hydroxysteroid dehydrogenase type 1 (HSD1) and 2 (HSD2) were quantified in placental biopsies. Results: In adjusted analyses women who reported higher depressive symptoms across the whole pregnancy had higher mRNA levels of GR [effect size 0.31 s.d. units, 95% confidence interval (CI) 0.01–0.60, p = 0.042] and MR (effect size 0.34 s.d. units, 95% CI 0.01–0.68, p = 0.047). These effects were significant for symptoms experienced in the third trimester of pregnancy for GR; findings for MR were also significant for symptoms experienced in the second trimester. GR and MR mRNA levels increased linearly by having the trimester-specific depressive symptoms scores 0, 1 or 2–3 times above the clinical cut-off for depression (p = 0.003, p = 0.049, respectively, and p = 0.004, p = 0.15 in adjusted analyses). Conclusions: Our findings offer potential gestational-age-specific mechanisms linking maternal depressive symptoms during pregnancy via placental biology. Future studies will test whether these also link with adverse offspring outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. (2008) · Epigenetics · doi:10.4161/epi.3.2.6034 · Cited by 1,432 · cited 3×
“Limitations of our study include the small sample size, though this was comparable with other studies in pregnant women (Oberlander et al. 2008; Devlin et al. 2010; O’Donnell et al. 2012; Hompes et al. 2013).”
BackgroundResultYehuda, R., Engel, S. M., Brand, S. R., Seckl, J., Marcus, S. M., & Berkowitz, G. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0550 · Cited by 711 · cited 1×
“For example, the third trimester has been shown to be a vulnerable time when maternal mental state and cortisol levels are linked to later offspring outcome (Yehuda et al. 2005).”
BackgroundSelf-citationPrenatal stress, glucocorticoids and the programming of adult disease
Cottrell, E. C. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.019.2009 · Cited by 640 · cited 1×
“© Cambridge University Press 2015 doi:10.1017/S003329171400316X ORIGINAL ARTICLE with adverse outcomes (Cottrell & Seckl, 2009).”
A transient placental source of serotonin for the fetal forebrain
Bonnin, A., Goeden, N., Chen, K., Wilson, M. L., King, J., Shih, J. C., Blakely, R. D., Deneris, E. S., & Levitt, P. (2011) · Nature · doi:10.1038/nature09972 · Cited by 608 · cited 1×
“The serotonin transporter (SLC6A4) mediates placental uptake of serotonin and the placenta is also able to synthesize serotonin frommaternal tryptophan precursors (Bonnin et al. 2011).”
BackgroundPrenatal depression effects on early development: A review
Field, T. (2011) · Infant Behavior and Development · doi:10.1016/j.infbeh.2010.09.008 · Cited by 592
HPA Axis Reactivity: A Mechanism Underlying the Associations Among 5-HTTLPR, Stress, and Depression
Gotlib, I. H., Joormann, J., Minor, K. L., & Hallmayer, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.008 · Cited by 558
Maternal prenatal anxiety and downregulation of placental 11β-HSD2
O’Donnell, K. J., Bugge Jensen, A., Freeman, L., Khalife, N., O’Connor, T. G., & Glover, V. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.014 · Cited by 449 · cited 8×
“2009) and in accordwith other published studies we found no significant associations between placental HSD2 mRNA levels and maternal depressive symptoms (Ponder et al. 2011; O’Donnell et al. 2012).”
BackgroundResultInfluentialDevlin, A. M., Brain, U., Austin, J., & Oberlander, T. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012201 · Cited by 308 · cited 3×
“Thus prenatal exposure to maternal depression has been associated with decreased methylation in umbilical cord leucocytes of SLC6A4 (Devlin et al. 2010) and increased methylation at the exon 1F promoter of NR3C1 (GR) in cord blood (Oberlander et al.”
BackgroundResultReynolds, R. M., Jacobsen, G. H., & Drake, A. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12164 · Cited by 71
Self-citation
Cited by
Van den Bergh, B. R. H., van den Heuvel, M. I., Lahti, M., Braeken, M., de Rooij, S. R., Entringer, S., Hoyer, D., Roseboom, T., Räikkönen, K., King, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.003 · Cited by 1,181
Self-citationHerba, C. M., Glover, V., Ramchandani, P. G., & Rondon, M. B. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30148-1 · Cited by 324
Glover, V., O'Donnell, K. J., O'Connor, T. G., & Fisher, J. (2018) · Development and Psychopathology · doi:10.1017/s095457941800038x · Cited by 271
“Maternal prenatal depression has been associated with an increase in the expression of NR3C1 in the placenta in several studies (Conradt, Lester, Appleton, Armstrong, & Marsit, 2013; Reynolds et al., 2015).”
BackgroundDashorst, P., Mooren, T. M., Kleber, R. J., de Jong, P. J., & Huntjens, R. J. C. (2019) · European Journal of Psychotraumatology · doi:10.1080/20008198.2019.1654065 · Cited by 207
“Besides the difference in parenting style between fathers and mothers it is becoming increasingly clear that severe stress in mothers during pregnancy can affect the development of the unborn child (Glover, 2015; Reynolds et al., 2015; Taouk & Schulkin, 2016).”
BackgroundJahnke, J. R., Terán, E., Murgueitio, F., Cabrera, H., & Thompson, A. L. (2021) · Placenta · doi:10.1016/j.placenta.2020.12.008 · Cited by 94
“Nonetheless, some studies report no differences in placental HSD11B2 measures based on anxiety [30], depression [30,40,45,46], or prenatal natural disasters [47].”
Background
Metadata
- Authors
- Reynolds, R. M., Pesonen, A.-K., O'Reilly, J. R., Tuovinen, S., Lahti, M., Kajantie, E., Villa, P. M., Laivuori, H., Hämäläinen, E., Seckl, J. R., & Räikkönen, K.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-01-28
- Volume
- 45
- Issue
- 10
- Pages
- 2023-2030
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2092458812
- Cited by
- 69
- References
- 9
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity. https://app.cochat.ai/papers/10.1017/s003329171400316x
- The paper
- Reynolds, R. M., Pesonen, A.-K., O'Reilly, J. R., Tuovinen, S., Lahti, M., Kajantie, E., Villa, P. M., Laivuori, H., Hämäläinen, E., Seckl, J. R., & Räikkönen, K. (2015). Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity. Psychological Medicine. https://doi.org/10.1017/s003329171400316x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.